NeoGenomics, Inc. Stock Issued During Period, Value, Acquisitions
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NeoGenomics, Inc. stock issued during period, value, acquisitions for the quarter ending 2021-06-30 was $29.18M.
- NeoGenomics, Inc. stock issued during period, value, acquisitions for fiscal 2021 was $29.18M.
- NeoGenomics, Inc. stock issued during period, value, acquisitions for fiscal 2018 was $13.24M.
- NeoGenomics, Inc. stock issued during period, value, acquisitions for fiscal 2015 was $102.51M.
| Period end | Stock Issued During Period, Value, Acquisitions 3 month | Stock Issued During Period, Value, Acquisitions 12 month |
|---|---|---|
| 2021-12-31 | $29.18M 10-K · filed 2024-02-20 | |
| 2021-06-30 | $29.18M 10-Q · filed 2022-11-08 | |
| 2018-12-31 | $13.24M 10-K · filed 2021-02-25 | |
| 2015-12-31 | $102.51M 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |